SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-322549
Filing Date
2018-11-08
Accepted
2018-11-08 16:11:01
Documents
3
Period of Report
2018-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d651564d8k.htm 8-K 16307
2 EX-99.1 d651564dex991.htm EX-99.1 64129
3 GRAPHIC g651564g93h40.jpg GRAPHIC 3784
  Complete submission text file 0001193125-18-322549.txt   86939
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Filer) CIK: 0001373707 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35837 | Film No.: 181169783
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1